Migdal Insurance & Financial Holdings’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,242	Closed	-$249K	–	763
2020 Q3	$249K	Buy	2,242 +1,160	+107%	+$125K	﹤0.01%	417
2020 Q2	$111K	Buy	+1,082	New	+$116K	﹤0.01%	408
2020 Q1	–	Sell	-414	Closed	-$48K	–	813
2019 Q4	$48K	Buy	414 +199	+93%	+$23K	﹤0.01%	636
2019 Q3	$25K	Buy	215 +12	+6%	+$1.19K	﹤0.01%	642
2019 Q2	$19K	Buy	203 +96	+90%	+$9.04K	﹤0.01%	688
2019 Q1	$10K	Buy	+107	New	+$8.76K	﹤0.01%	670

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.38% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Migdal Insurance & Financial Holdings's CBPO Position: Q4 2020 in Review

Migdal Insurance & Financial Holdings sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2020, closing a stake of 2,242 shares — an estimated $249K sold.

Migdal Insurance & Financial Holdings first reported a position in CBPO in Q1 2019 and held it in 6 quarters. The position peaked at $249K in Q3 2020. 89 funds tracked by Wall St. Rank hold CBPO as of Q4 2020.

Migdal Insurance & Financial Holdings reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2020 after selling out during the quarter.
Migdal Insurance & Financial Holdings sold 2,242 China Biologic Products Holdings, Inc. shares in Q4 2020, an estimated $249K.
Migdal Insurance & Financial Holdings first reported a position in China Biologic Products Holdings, Inc. in Q1 2019 and held it in 6 quarters.
Migdal Insurance & Financial Holdings's China Biologic Products Holdings, Inc. position peaked at $249K in Q3 2020.
89 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2020.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q4 2020, filed 8 Feb 2021.